Nuzenio

Pulmonary Sarcoidosis

Pulmonary Sarcoidosis news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Researchers uncover new insights into immune cell activity in sarcoidosis - Bioengineer.orgBioengineer.org · Mon, 10 Aug 2026 22:09:51 GMTStudy identifies key immune cell changes in the lungs of people with sarcoidosis - News-MedicalNews-Medical · Mon, 10 Aug 2026 19:47:00 GMTUnusual Presentation of Sarcoidosis: Biliary... : American Journal of Gastroenterology - Lippincott HomeLippincott Home · Sat, 08 Aug 2026 22:13:38 GMTTherapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosis - ERS - European Respiratory SocietyERS - European Respiratory Society · Sat, 08 Aug 2026 20:06:01 GMTaTyr Pharma Prioritizes Efzofitimod Program, Cuts Workforce 60% as FDA Feedback on Phase 3 Sarcoidosis Study Protocol Looms - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 20:10:00 GMTaTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 20:05:54 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - HCPLiveHCPLive · Fri, 07 Aug 2026 14:06:13 GMTStudy links manual work to higher risk of sarcoidosis - Sarcoidosis NewsSarcoidosis News · Wed, 05 Aug 2026 01:07:15 GMT

Timeline

Mon, 10 Aug 2026 22:09:51 GMTResearchers uncover new insights into immune cell activity in sarcoidosis - Bioengineer.org
Mon, 10 Aug 2026 19:47:00 GMTStudy identifies key immune cell changes in the lungs of people with sarcoidosis - News-Medical
Sat, 08 Aug 2026 22:13:38 GMTUnusual Presentation of Sarcoidosis: Biliary... : American Journal of Gastroenterology - Lippincott Home
Sat, 08 Aug 2026 20:06:01 GMTTherapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosis - ERS - European Respiratory Society
Fri, 07 Aug 2026 20:10:00 GMTaTyr Pharma Prioritizes Efzofitimod Program, Cuts Workforce 60% as FDA Feedback on Phase 3 Sarcoidosis Study Protocol Looms - Quiver Quantitative
Fri, 07 Aug 2026 20:05:54 GMTaTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD - The Manila Times

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pulmonary Sarcoidosis.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.